MXCT (MaxCyte Inc.): Time to Pay Attention?

After finishing at $5.33 in the prior trading day, MaxCyte Inc. (NASDAQ: MXCT) closed at $5.48, up 2.81%. In other words, the price has increased by $+0.15 from its previous closing price. On the day, 554087 shares were traded. MXCT stock price reached its highest trading level at $5.51 during the session, while it also had its lowest trading level at $5.24.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Ratios:

Our goal is to gain a better understanding of MXCT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.60 and its Current Ratio is at 15.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On August 24, 2021, Wedbush started tracking the stock assigning a Outperform rating and target price of $36.Wedbush initiated its Outperform rating on August 24, 2021, with a $36 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 05 when Doerfler Douglas sold 10,234 shares for $5.04 per share. The transaction valued at 51,579 led to the insider holds 333,197 shares of the business.

Ross Thomas M. sold 9,467 shares of MXCT for $47,714 on Jan 05. The EVP, Global Sales & Marketing now owns 0 shares after completing the transaction at $5.04 per share. On Jan 04, another insider, Doerfler Douglas, who serves as the President and CEO of the company, sold 9,153 shares for $5.07 each. As a result, the insider received 46,406 and left with 333,197 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 12.96 while its Price-to-Book (P/B) ratio in mrq is 2.19.

Stock Price History:

Over the past 52 weeks, MXCT has reached a high of $7.76, while it has fallen to a 52-week low of $3.36. The 50-Day Moving Average of the stock is 5.68, while the 200-Day Moving Average is calculated to be 5.52.

Shares Statistics:

The stock has traded on average 346.88K shares per day over the past 3-months and 495.38k shares per day over the last 10 days, according to various share statistics. A total of 101.81M shares are outstanding, with a floating share count of 96.75M. Insiders hold about 1.25% of the company’s shares, while institutions hold 85.40% stake in the company. Shares short for MXCT as of Oct 13, 2022 were 3.03M with a Short Ratio of 1.92M, compared to 1.99M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.98% and a Short% of Float of 3.51%.

Earnings Estimates

Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.09 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.1, while EPS last year was -$0.03. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.26 and -$0.3 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.3, with 5 analysts recommending between -$0.24 and -$0.36.

Revenue Estimates

5 analysts predict $10.43M in revenue for the current quarter. It ranges from a high estimate of $10.9M to a low estimate of $10.08M. As of the current estimate, MaxCyte Inc.’s year-ago sales were $10.14M, an estimated increase of 2.90% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $13.07M, an increase of 28.70% over than the figure of $2.90% in the same quarter last year. There is a high estimate of $13.48M for the next quarter, whereas the lowest estimate is $12.5M.

A total of 5 analysts have provided revenue estimates for MXCT’s current fiscal year. The highest revenue estimate was $45M, while the lowest revenue estimate was $44.1M, resulting in an average revenue estimate of $44.7M. In the same quarter a year ago, actual revenue was $33.89M, up 31.90% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $57.86M in the next fiscal year. The high estimate is $60.6M and the low estimate is $55M. The average revenue growth estimate for next year is up 29.40% from the average revenue estimate for this year.